Effects of riboflavin in children with complex II deficiency

Marianna Bugiani1, Eleonora Lamantea, Federica Invernizzi

  • 1Department of Child Neurology, Istituto Nazionale Neurologico C. Besta, Milano, Italy. mbugiani@istituto-besta.it

Brain & Development
|June 2, 2006
PubMed

Insights

Riboflavin treatment shows promise for children with complex II deficiency, a rare mitochondrial disease. Supplementation stabilized or improved neurological conditions and reduced lactate levels in patients, suggesting a potential therapeutic approach.

Area of Science:

  • Biochemistry
  • Pediatric Neurology
  • Mitochondrial Medicine

Background:

  • Isolated complex II deficiency is a rare, progressive mitochondrial disease in children.
  • Current treatments are lacking, leading to severe motor and mental deterioration.
  • Mitochondrial dysfunction impacts cellular energy production and overall health.

Purpose of the Study:

  • To investigate the efficacy of riboflavin as a treatment for isolated complex II deficiency.
  • To assess the impact of riboflavin on neurological status and metabolic markers in affected children.
  • To evaluate the effect of riboflavin on complex II activity in patient-derived cells.

Main Methods:

  • Case series of three children with complex II deficiency treated with oral riboflavin.
  • Longitudinal follow-up for a mean of 4.5 years, monitoring neurological and growth parameters.
  • Biochemical analysis of plasma lactate levels and in vitro study of riboflavin's effect on fibroblast complex II activity.

Main Results:

  • Two patients with leukoencephalopathy showed stable or improved neurological conditions.
  • The third patient experienced decreased plasma lactate levels and no neurological decline.
  • Riboflavin increased complex II activity in cultured patient fibroblasts, but not in controls.

Conclusions:

  • Riboflavin supplementation may be a beneficial treatment for isolated complex II deficiency.
  • Early intervention with riboflavin could potentially halt or reverse disease progression.
  • Further research is warranted to confirm riboflavin's therapeutic role in this condition.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Role of Reduced Coenzymes NADH and FADH₂01:29

Role of Reduced Coenzymes NADH and FADH₂

The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...